Professor, Medicine, University of Colorado School of Medicine
Hematology
Dr. Madeleine A. Kane, MD
|
|
Give Review
Madeleine Kane practices Hematology. She graduated from University of Miami Miller School of Medicine. University of Miami Miller School of Medicine is ranked 45 in research and 0 in primary care medicine She received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification" and "CORE Magazine". Madeleine Kane is a published doctor. She published 45 publications, including: 'Properties of classic protein kinase C in human small cell lung carcinoma NCI-H345 cells.' She accepts all Medicare patients.
Publications
- A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer.
- Approach to the thyroid Cancer patient with extracervical metastases.
- Axitinib is an active treatment for all histologic subtypes of advanced thyroid Cancer: results from a phase II study.
- A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck Cancer patients.
- Chemoprevention of squamous cell Carcinoma of the oral cavity.
- Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell Carcinoma of the head and neck.
- Immune reconstitution inflammatory Syndrome associated with Kaposi sarcoma during potent antiretroviral therapy.
- Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers: a potential risk marker for smoking-related Diseases.
- Medical oncology in a sophomore medical student pathophysiology course.
- Novel bombesin-like peptide binding proteins from Lung.
- Triple-modality therapy for a woman with locally advanced thoracic esophageal adenoCarcinoma, Part 2.
- The promise of stereotactic body radiation therapy in a new era of oncology.
- Increased levels of bombesin-like peptides in the lower respiratory Tract of asymptomatic cigarette smokers.
- Oncogenic signaling.
- Melatonin interactions with cultured murine B16 melanoma cells.
- Role of folate binding proteins in folate metabolism.
- Serum melatonin levels in melanoma patients after repeated oral administration.
- Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma.
- Growth factors in lung Cancer: possible etiologic role and clinical target.
- Bombesin-like peptide receptors in human bronchial epithelial cells.
- Isolation of a gastrin releasing peptide receptor from normal rat pancreas.
- Isolation of the bombesin/gastrin-releasing peptide receptor from human small cell lung Carcinoma NCI-H345 cells.
- A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate Cancer.
- Innovative and future approaches to small cell lung Cancer treatment.
- The use of trastuzumab in the treatment of hormone refractory prostate Cancer; phase II trial.
- Novel soluble, high-affinity gastrin-releasing peptide binding proteins in Swiss 3T3 fibroblasts.
- Properties of classic protein kinase C in human small cell lung Carcinoma NCI-H345 cells.
- Survival and patterns of relapse in patients with oral tongue Cancer.
- Effect of radiation techniques in treatment of oropharynx Cancer.
- Nonconstitutive expression of the gastrin-releasing peptide autocrine growth System in human small cell lung carcinoma NCI-H345 cells.
- Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell Carcinoma: a phase II, randomized, double-blind, placebo-controlled study.
- Clinical correlates of bombesin-like peptide receptor subtype expression in human lung Cancer cells.
- Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal Cancer: a phase II trial.
- Multi-institutional phase I/II trial of stereotactic body radiation therapy for Liver metastases.
- Outcomes of patients with n3 neck nodes treated with chemoradiation.
- Results of a phase I trial of 12 patients with locally advanced pancreatic Carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of ...
- Nicotine effects on proliferation and the bombesin-like peptide autocrine System in human small cell lung carcinoma SHP77 cells in culture.
- Multi-institutional phase I/II trial of stereotactic body radiation therapy for Lung metastases.
- Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck Cancer.
- Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck Cancer.
- Dexamethasone regulation of gastrin-releasing peptide receptor in human Lung cells.
- Transfusion-related Acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carc...
- Inhibition of proliferation of human small cell lung Cancer cells expressing an autocrine system for gastrin releasing peptide by antisense oligodeoxynucleotides to ga...
- The role of folates in squamous cell Carcinoma of the head and neck.
Schools
University Of Miami Leonard M Miller School Of Medicine
Stanford Hospital and Clinics Program
University Of Colorado University Hospital Program
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- CORE Magazine
Education
-
University of Colorado -
Stanford University -
University of Miami Miller School of Medicine
Hospital
-
University of Colorado Hospital -
Denver Health
Drug Facts
| NPI NUMBER | 1528034964 | |
| NPPES Provider LastName | KANE | |
| NPPES Provider FirstName | MADELEINE | |
| NPPES Provider ZIPCode | 800452517 | |
| NPPES Provider State | CO | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 652.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 119.0 | |
| Percent Opioid Claims | 18.25 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1528034964 |
| Last Name Of The Provider | KANE |
| First Name Of The Provider | MADELEINE |
| View All |
Similar Doctors
|
Dr. William T. Purcell, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles M. Nieto, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sujatha Nallapareddy, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas W. Flaig, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kathryn L. Hassell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David C. Faragher, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sally P. Stabler, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Robert H. Allen, MD |
|
Dr. Stuart E. Lind, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Stephen Leong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel W. Bowles, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William Robinson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Verlyn Peterson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karl D. Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manali K. Kamdar, MD |
|
|
Dr. Amelia C. Ashmann, MD |
|
|
Dr. Andrew T. Johnson, MD |
|
|
Nitya Alluri |
|
|
Dr. Zohra I. Nooruddin, MD |